Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | TYR | P14679 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Cymene SCHEMBL3684076 | 1.00 | ACHE (0.50) | ACHETDP1CHRNA7TYRBCHE | |
| P-Cymene SCHEMBL29006180 | 1.00 | ACHE (0.50) | ACHETDP1CHRNA7TYRBCHE | |
| P-Cymene SCHEMBL30626114 | 0.97 | ACHE (0.47) | ACHETDP1CHRNA7TYRBCHE | |
| P-Cymene SCHEMBL6274941 | 0.97 | ACHE (0.47) | ACHETDP1CHRNA7TYRBCHE | |
| P-Cymene SCHEMBL6510505 | 0.97 | ACHE (0.47) | ACHETDP1CHRNA7TYRBCHE | |
| P-Cymene SCHEMBL2570692 | 0.97 | ACHE (0.47) | ACHETDP1CHRNA7TYRBCHE | |
| P-Cymene SCHEMBL4005540 | 0.97 | ACHE (0.47) | ACHETDP1CHRNA7TYRBCHE | |
| P-Cymene SCHEMBL1143 | 0.97 | ACHE (0.53) | ACHETDP1CHRNA7TYRBCHE | |
| P-Cymene SCHEMBL1697748 | 0.97 | ACHE (0.53) | ACHETDP1CHRNA7TYRBCHE | |
| P-Cymene SCHEMBL1897619 | 0.94 | ACHE (0.44) | ACHETDP1CHRNA7TYRBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119505185-A | PAF supported ruthenium catalyst and preparation method and application thereof | 南昌大学 | 2025-02-25 | — | — | CN | claimed |
| CN-119191978-A | Method for synthesizing meta-secondary alkyl substituted aryl carboxylic acid | 华南理工大学 | 2024-12-27 | — | — | CN | claimed |
| CN-119101254-A | COF composite material and preparation method and application thereof | 南昌大学 | 2024-12-10 | — | — | CN | claimed |
| CN-118684579-A | Method for preparing 2-methyl-4-acetoxyl-2-butenal by one-step method | 浙江芳原馨生物医药有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-117924171-A | Phenanthrone derivative and synthesis method thereof | 华南理工大学 | 2024-04-26 | — | — | CN | claimed |
| CN-117902990-A | Preparation method of ilalastine intermediate (R) -6- (2-amino-4-methoxyphenyl) -5,6,7, 8-tetrahydronaphthalene-2-ol | 海化生命(厦门)科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117886819-A | Synthesis method of L-5-methyltetrahydrofolate and calcium salt thereof | 无锡紫杉药业股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117820380-A | Ruthenium complex with light responsiveness and preparation method and application thereof | 广西医科大学 | 2024-04-05 | — | — | CN | claimed |
| CN-117776958-A | Aromatic hydrocarbon carboxylic acid meta-position alkylation product and synthesis method thereof | 华南理工大学 | 2024-03-29 | — | — | CN | claimed |
| CN-117736224-A | Synthetic method of spiropyran compound | 河南农业大学 | 2024-03-22 | — | — | CN | claimed |
| CN-109195937-A | Acetic acid and hydrogen are generated in water-bearing media by ethyl alcohol and acetaldehyde by organic/inorganic catalyst | 沙特基础工业全球技术公司 | 2019-01-11 | — | — | CN | claimed |
| US-10053480-B1 | Anti-quorum and DNA cleaving agent | KING SAUD UNIVERSITY (SA) | 2018-08-21 | — | — | US | claimed |
| EP-2906569-B1 | HYDROSILYLATION SYNTHESIS OF HALOALKYLORGANOSILANES USING PEROXIDE PROMOTERS | MOMENTIVE PERFORMANCE MAT INC (US) | 2018-06-13 | — | — | EP | claimed |
| CN-105294449-B | Preparation method for (R)-(+)-1-(1-naphthyl)ethylamine and (S)-(-)-1-(1-naphthyl)ethylamine | 连云港手性化学有限公司 | 2017-02-08 | — | — | CN | claimed |
| CN-105294449-A | Preparation method for (R)-(+)-1-(1-naphthyl)ethylamine and (S)-(-)-1-(1-naphthyl)ethylamine | LIANYUNGANG CHIRAL CHEMICAL CHINA CO LTD | 2016-02-03 | — | — | CN | claimed |
| CN-105189419-A | Metathesis process comprising the extraction of the ethylene formed by means of a membrane | ARKEMA FRANCE | 2015-12-23 | — | — | CN | claimed |
| CN-103003231-A | Novel method for preparing phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor | ACTAVIS GROUP PTC EHF | 2013-03-27 | — | — | CN | claimed |
| CN-102264672-A | Process for preparing optically active compounds using transfer hydrogenation | — | 2011-11-30 | — | — | CN | claimed |
| WO-2002040494-A1 | RUTHENIUM-ARYL-COMPOUNDS IN CANCER THERAPY | UNIVERSITY OF YORK (GB) | 2002-05-23 | — | — | WO | claimed |
| CN-1349971-A | Olfination method of itaconic acid and succinic acid derivatives | PFIZER (US) | 2002-05-22 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10053480-B1 | Anti-quorum and DNA cleaving agent | API5, RNGTT, XRCC6 | ACHE 938/4885TDP1 34/4885CHRNA7 3498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.